Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-23-081556
Filing Date
2023-10-30
Accepted
2023-10-30 16:30:44
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea187369-f1_purplebio.htm F-1 378633
2 OPINION OF FISCHER (FBC & CO.) ea187369ex5-1_purplebio.htm EX-5.1 9427
3 OPINION OF HAYNES AND BOONE, LLP, U.S. LEGAL COUNSEL TO THE REGISTRANT ea187369ex5-2_purplebio.htm EX-5.2 8615
4 CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB ea187369ex23-3_purplebio.htm EX-23.3 2198
5 FILING FEE TABLE ea187369ex-fee_purplebio.htm EX-FILING FEES 82857
6 GRAPHIC image_001.jpg GRAPHIC 6903
7 GRAPHIC ex5-1_001.jpg GRAPHIC 19945
  Complete submission text file 0001213900-23-081556.txt   520182
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-275216 | Film No.: 231360735
SIC: 2834 Pharmaceutical Preparations